Cargando…

Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis

Viral infections have been suspected of being involved in the pathogenesis of certain autoimmune diseases for many years. Epstein-Barr virus (EBV), a DNA virus belonging to the Herpesviridae family, is thought to be associated with the onset and/or the progression of multiple sclerosis (MS), systemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debuysschere, Cyril, Nekoua, Magloire Pandoua, Hober, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220565/ https://www.ncbi.nlm.nih.gov/pubmed/37317236 http://dx.doi.org/10.3390/microorganisms11051262

Ejemplares similares

Viruses and Endocrine Diseases
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2023)

Coxsackievirus Infection and Associated Diseases
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2022)

Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2022)

The Fight against Poliovirus Is Not Over
por: Mbani, Chaldam Jespère, et al.
Publicado: (2023)

Fighting Enteroviral Infections to Prevent Type 1 Diabetes
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2022)

Enteroviral Pathogenesis of Type 1 Diabetes: The Role of Natural Killer Cells
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2020)

Epstein–Barr virus and multiple sclerosis
por: Soldan, Samantha S., et al.
Publicado: (2022)

Enteroviruses and Type 1 Diabetes Mellitus: An Overlooked Relationship in Some Regions
por: Alhazmi, Abdulaziz, et al.
Publicado: (2020)

Low Serum Levels of Interferon Alpha in COVID-19 Patients Are Associated with Older Age
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2022)

Epstein-Barr Virus and Multiple Sclerosis
por: Houen, Gunnar, et al.
Publicado: (2020)

Risk of Multiple Sclerosis in Epstein–Barr Virus Infection
por: Ahmed, Syed Ijlal, et al.
Publicado: (2019)

Effect of Coxsackievirus B4 Infection on the Thymus: Elucidating Its Role in the Pathogenesis of Type 1 Diabetes
por: Alhazmi, Abdulaziz, et al.
Publicado: (2021)

Fluoxetine Can Inhibit SARS-CoV-2 In Vitro
por: Dechaumes, Arthur, et al.
Publicado: (2021)

Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy
por: Pender, Michael P, et al.
Publicado: (2014)

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
por: Bar-Or, Amit, et al.
Publicado: (2020)

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
por: Serafini, Barbara, et al.
Publicado: (2007)

Smoking and Epstein–Barr virus infection in multiple sclerosis development
por: Hedström, Anna Karin, et al.
Publicado: (2020)

Infection with Epstein Barr virus increases risk of multiple sclerosis
por: Barnes, Katharine
Publicado: (2022)

Epstein-Barr virus infection: the leading cause of multiple sclerosis
por: He, Ruirui, et al.
Publicado: (2022)

Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection
por: Hedström, Anna Karin
Publicado: (2023)

Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2017)

Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2017)

The enigmatic links between Epstein-Barr virus infection and multiple sclerosis
por: Tyler, Kenneth L.
Publicado: (2022)

Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2021)

Effectiveness of Antihyperglycemic Effect of Momordica charantia: Implication of T-Cell Cytokines
por: Fachinan, Rufine, et al.
Publicado: (2017)

Epstein Barr Virus Exploits Genetic Susceptibility to Increase Multiple Sclerosis Risk
por: Läderach, Fabienne, et al.
Publicado: (2021)

Altered Immune Response to the Epstein–Barr Virus as a Prerequisite for Multiple Sclerosis
por: Läderach, Fabienne, et al.
Publicado: (2022)

Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
por: Maghzi, Amir-Hadi, et al.
Publicado: (2011)

The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
por: Pender, Michael P.
Publicado: (2011)

A role for the Epstein–Barr virus in multiple sclerosis aetiology?
por: Hrastelj, J., et al.
Publicado: (2022)

Inflammation and Epstein–Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection
por: Rousseau, Beth A., et al.
Publicado: (2023)

The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging
por: Guan, Yi, et al.
Publicado: (2019)

Epstein-Barr virus infection mechanisms
por: Chesnokova, Liudmila S., et al.
Publicado: (2014)

Virological Markers in Epstein–Barr Virus-Associated Diseases
por: Lupo, Julien, et al.
Publicado: (2023)

Epstein–Barr virus and multiple sclerosis: the dawn of a new age
por: Phan, Tri Giang
Publicado: (2023)

Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2014)

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
por: Pender, Michael P., et al.
Publicado: (2020)

Epstein–Barr Virus and Multiple Sclerosis: Wrong Place, Wrong Time?
por: Maghzi, Amir-Hadi, et al.
Publicado: (2011)

Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism
por: Thomas, Olivia G, et al.
Publicado: (2023)

Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis
por: Smith, Corey, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kmlpe03r6lfmsl0aqk1gbmuoe4